Scantlebery, A. M. L., Uil, M., Butter, L. M., Poelman, R., Claessen, N., Girardin, S. E., . . . Leemans, J. C. (2019). NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin. PloS one, 14(3), e0214437. https://doi.org/10.1371/journal.pone.0214437
Chicago-Zitierstil (17. Ausg.)Scantlebery, Angelique M. L., Melissa Uil, Loes M. Butter, Renée Poelman, Nike Claessen, Stephen E. Girardin, Sandrine Florquin, Joris J. T. H. Roelofs, und Jaklien C. Leemans. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced by Multiple Low Doses of Streptozotocin." PloS One 14, no. 3 (2019): e0214437. https://doi.org/10.1371/journal.pone.0214437.
MLA-Zitierstil (9. Ausg.)Scantlebery, Angelique M. L., et al. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced by Multiple Low Doses of Streptozotocin." PloS One, vol. 14, no. 3, 2019, p. e0214437, https://doi.org/10.1371/journal.pone.0214437.